BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 9553767)

  • 1. Ecto-enzyme and signaling functions of lymphocyte CD73.
    Resta R; Yamashita Y; Thompson LF
    Immunol Rev; 1998 Feb; 161():95-109. PubMed ID: 9553767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol-anchored lymphocyte differentiation antigen ecto-5'-nucleotidase (CD73).
    Thomson LF; Ruedi JM; Glass A; Moldenhauer G; Moller P; Low MG; Klemens MR; Massaia M; Lucas AH
    Tissue Antigens; 1990 Jan; 35(1):9-19. PubMed ID: 2137649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased number of CD73 (ecto-5'-nucleotidase) molecules on lymphocytes from patients with primary immunoglobulin deficiencies. Correlation between number of CD73 molecules and T-lymphocyte function in vitro.
    Christensen LD; Andersen V; Ryder L
    Scand J Immunol; 1996 Jul; 44(1):62-70. PubMed ID: 8693293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosyl phosphatidylinositol membrane anchor is not required for T cell activation through CD73.
    Resta R; Hooker SW; Laurent AB; Shuck JK; Misumi Y; Ikehara Y; Koretzky GA; Thompson LF
    J Immunol; 1994 Aug; 153(3):1046-53. PubMed ID: 8027539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell signalling through CD73.
    Resta R; Thompson LF
    Cell Signal; 1997 Feb; 9(2):131-9. PubMed ID: 9113412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD73 expression and fyn-dependent signaling on murine lymphocytes.
    Yamashita Y; Hooker SW; Jiang H; Laurent AB; Resta R; Khare K; Coe A; Kincade PW; Thompson LF
    Eur J Immunol; 1998 Oct; 28(10):2981-90. PubMed ID: 9808167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation and function of CD73, a glycosyl-phosphatidylinositol-linked 70-kD adhesion molecule, on lymphocytes and endothelial cells.
    Airas L; Niemelä J; Salmi M; Puurunen T; Smith DJ; Jalkanen S
    J Cell Biol; 1997 Jan; 136(2):421-31. PubMed ID: 9015312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD73 engagement promotes lymphocyte binding to endothelial cells via a lymphocyte function-associated antigen-1-dependent mechanism.
    Airas L; Niemelä J; Jalkanen S
    J Immunol; 2000 Nov; 165(10):5411-7. PubMed ID: 11067892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective induction of CD73 expression in human lymphocytes by CD38 ligation: a novel pathway linking signal transducers with ecto-enzyme activities.
    Peola S; Borrione P; Matera L; Malavasi F; Pileri A; Massaia M
    J Immunol; 1996 Nov; 157(10):4354-62. PubMed ID: 8906810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ecto-5'-nucleotidase/CD73 enhances endothelial barrier function and sprouting in blood but not lymphatic vasculature.
    Yegutkin GG; Auvinen K; Rantakari P; Hollmén M; Karikoski M; Grénman R; Elima K; Jalkanen S; Salmi M
    Eur J Immunol; 2015 Feb; 45(2):562-73. PubMed ID: 25402681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD73-generated adenosine restricts lymphocyte migration into draining lymph nodes.
    Takedachi M; Qu D; Ebisuno Y; Oohara H; Joachims ML; McGee ST; Maeda E; McEver RP; Tanaka T; Miyasaka M; Murakami S; Krahn T; Blackburn MR; Thompson LF
    J Immunol; 2008 May; 180(9):6288-96. PubMed ID: 18424752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-alpha induced adenosine production on the endothelium: a mechanism mediated by CD73 (ecto-5'-nucleotidase) up-regulation.
    Niemelä J; Henttinen T; Yegutkin GG; Airas L; Kujari AM; Rajala P; Jalkanen S
    J Immunol; 2004 Feb; 172(3):1646-53. PubMed ID: 14734746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity and expression of ecto-5'-nucleotidase/CD73 are increased by thyroid hormones in vascular smooth muscle cells.
    Tamajusuku AS; Carrillo-Sepúlveda MA; Braganhol E; Wink MR; Sarkis JJ; Barreto-Chaves ML; Battastini AM
    Mol Cell Biochem; 2006 Sep; 289(1-2):65-72. PubMed ID: 16718378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73.
    Airas L; Hellman J; Salmi M; Bono P; Puurunen T; Smith DJ; Jalkanen S
    J Exp Med; 1995 Nov; 182(5):1603-8. PubMed ID: 7595232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine Formed by CD73 on T Cells Inhibits Cardiac Inflammation and Fibrosis and Preserves Contractile Function in Transverse Aortic Constriction-Induced Heart Failure.
    Quast C; Alter C; Ding Z; Borg N; Schrader J
    Circ Heart Fail; 2017 Apr; 10(4):. PubMed ID: 28404626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of ecto-5'-nucleotidase (CD73) in normal mammary gland and in breast carcinoma.
    Krüger KH; Thompson LF; Kaufmann M; Möller P
    Br J Cancer; 1991 Jan; 63(1):114-8. PubMed ID: 1989648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No correlation between CD73 expression and ecto-5'-nucleotidase activity on blood mononuclear cells in vitro. Evidence of CD73 (ecto-5'-nucleotidase) on blood mononuclear cells with distinct antigenic properties.
    Christensen LD
    APMIS; 1996 Feb; 104(2):126-34. PubMed ID: 8619914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ecto-5'-nucleotidase/CD73 contributes to the radiosensitivity of T24 human bladder cancer cell line.
    Dietrich F; Figueiró F; Filippi-Chiela EC; Cappellari AR; Rockenbach L; Tremblay A; de Paula PB; Roesler R; Filho AB; Sévigny J; Morrone FB; Battastini AMO
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):469-482. PubMed ID: 29305710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression.
    Jin D; Fan J; Wang L; Thompson LF; Liu A; Daniel BJ; Shin T; Curiel TJ; Zhang B
    Cancer Res; 2010 Mar; 70(6):2245-55. PubMed ID: 20179192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD73 on T Cells Orchestrates Cardiac Wound Healing After Myocardial Infarction by Purinergic Metabolic Reprogramming.
    Borg N; Alter C; Görldt N; Jacoby C; Ding Z; Steckel B; Quast C; Bönner F; Friebe D; Temme S; Flögel U; Schrader J
    Circulation; 2017 Jul; 136(3):297-313. PubMed ID: 28432149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.